Newsroom
Top Results
Sight Sciences to Present at the Upcoming Bank of America Healthcare Conference
MENLO PARK, Calif., April 29, 2022 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today announced plans to participate in the upcoming Bank of America Healthcare Conference. Sight Sciences’ management is scheduled to present Thursday, May 12, 2022, […]
Sight Sciences Announces Multiple Presentations and Event at the 2022 American Society of Cataract and Refractive Surgery Annual Meeting
PDF Version MENLO PARK, Calif., April 20, 2022 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today announced that data from clinical studies of the OMNI® Surgical System will be presented at the 2022 American Society of Cataract and Refractive Surgery […]
Sight Sciences Reports Fourth Quarter and Full Year 2021 Financial Results
MENLO PARK, Calif., March 24, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients’ lives, today reported financial results for the quarter and year ended December 31, 2021.
Sight Sciences Announces First Patient Treated in TRIDENT European Trial to Evaluate the OMNI® Surgical System in Pseudophakic Eyes with Open-Angle Glaucoma
Novel trial design will compare safety and effectiveness outcomes for the OMNI Surgical System and the iStent inject® in lowering intraocular pressure (IOP) as a standalone treatment option without concomitant cataract surgery.
Sight Sciences Announces Appointment of Brenda Becker to Board of Directors
Legislative and health policy expert brings extensive private and public sector experience
Sight Sciences Announces Multiple Presentations at the 2022 American Glaucoma Society Annual Meeting
MENLO PARK, Calif.— March 2, 2022 — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today announced that data from clinical studies of the OMNI® Surgical System will be presented at the 2022 American Glaucoma Society (AGS) Annual Meeting. The conference […]
Sight Sciences Launches “Don’t Wait for Too Late” Awareness Campaign for Glaucoma
Educational campaign aims to raise awareness among the optometric community of minimally invasive glaucoma surgery (MIGS) as an earlier surgical intervention for glaucoma
Sight Sciences Receives FDA 510(k) Clearance of the TearCare® System for Treatment of Meibomian Gland Dysfunction (MGD), the Leading Cause of Dry Eye Disease
Label expansion for evaporative dry eye due to MGD will support further efforts to drive patient access to insurance-covered TearCare treatments